BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31058792)

  • 1. Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
    Tokatly Latzer I; Nahum E; Cavari Y; Lazar I; Ben-Ari Y; Ben-Shimol S; Ben-Shalom G; Geffen Y; Goldberg L; Rubinstein M; Keller N; Pessach IM; Paret G
    Pediatr Crit Care Med; 2019 May; 20(5):e231-e239. PubMed ID: 31058792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Stenotrophomonas maltophilia Infections in Critically Ill Children.
    Tokatly Latzer I; Paret G; Rubinstein M; Keller N; Barkai G; Pessach IM
    Pediatr Infect Dis J; 2018 Oct; 37(10):981-986. PubMed ID: 29634621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
    Alsuhaibani M; Aljarbou A; Althawadi S; Alsweed A; Al-Hajjar S
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):19. PubMed ID: 33482916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.
    Ebara H; Hagiya H; Haruki Y; Kondo E; Otsuka F
    Intern Med; 2017; 56(2):137-142. PubMed ID: 28090041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
    J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features, Outcomes, and Risk Factors of Bloodstream Infections due to
    Chen Y; Suo J; Du M; Chen L; Liu Y; Wang L; Liang Z
    Biomed Res Int; 2019; 2019():4931501. PubMed ID: 31886220
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
    Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
    BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for death from Stenotrophomonas maltophilia bacteremia.
    Osawa K; Shigemura K; Kitagawa K; Tokimatsu I; Fujisawa M
    J Infect Chemother; 2018 Aug; 24(8):632-636. PubMed ID: 29673561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.
    Ko JH; Kang CI; Cornejo-Juárez P; Yeh KM; Wang CH; Cho SY; Gözel MG; Kim SH; Hsueh PR; Sekiya N; Matsumura Y; Lee DG; Cho SY; Shiratori S; Kim YJ; Chung DR; Peck KR
    Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
    Hand E; Davis H; Kim T; Duhon B
    J Antimicrob Chemother; 2016 Apr; 71(4):1071-5. PubMed ID: 26801080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and characteristics of 16 cases with Stenotrophomonas maltophilia bacteraemia in pediatric Intensive Care Units.
    Motamedifar M; Heidari H; Yasemi M; Sedigh Ebrahim-Saraie H
    Ann Ig; 2017; 29(4):264-272. PubMed ID: 28569336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
    Kim SH; Cho SY; Kang CI; Seok H; Huh K; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
    Ann Hematol; 2018 Feb; 97(2):343-350. PubMed ID: 29138886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
    Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
    J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Stenotrophomonas maltophilia bacteremia in children.
    Furuichi M; Ito K; Miyairi I
    Pediatr Int; 2016 Feb; 58(2):113-8. PubMed ID: 26139084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.
    Watson L; Esterly J; Jensen AO; Postelnick M; Aguirre A; McLaughlin M
    J Glob Antimicrob Resist; 2018 Mar; 12():104-106. PubMed ID: 28964955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial
    Hevia EC; Wooten L; Carr AL
    Ann Pharmacother; 2024 Jul; 58(7):698-704. PubMed ID: 37776160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
    Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
    J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience.
    Arthur C; Tang X; Romero JR; Gossett JG; Harik N; Prodhan P
    Pediatr Cardiol; 2015 Mar; 36(3):509-15. PubMed ID: 25293429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stenotrophomonas maltophilia bacteraemia in Turkish children.
    Güriz H; Ciftçi E; Ayberkin E; Aysev D; Ince E; Arsan S; Yavuz G; Doğru U
    Ann Trop Paediatr; 2008 Jun; 28(2):129-36. PubMed ID: 18510823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenotrophomonas maltophilia bacteremia in children - A 10-year analysis.
    Büyükcam A; Bıçakcıgil A; Cengiz AB; Sancak B; Ceyhan M; Kara A
    Arch Argent Pediatr; 2020 Jun; 118(3):e317-e323. PubMed ID: 32470274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.